MCM7
Basic information
Region (hg38): 7:100092233-100101940
Previous symbols: [ "MCM2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Meier-Gorlin syndrome (4 variants)
- 9 conditions (2 variants)
- Hereditary spastic paraplegia 50 (2 variants)
- Abnormality of the nervous system (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCM7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 66 | 71 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 14 | 17 | 43 | |||
Total | 8 | 4 | 80 | 20 | 10 |
Highest pathogenic variant AF is 0.00000662
Variants in MCM7
This is a list of pathogenic ClinVar variants found in the MCM7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-100092988-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
7-100093021-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
7-100093033-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
7-100093051-C-G | not specified | Uncertain significance (Jul 29, 2022) | ||
7-100093055-C-G | not specified | Uncertain significance (Jul 25, 2023) | ||
7-100093099-C-T | not specified | Likely benign (Feb 05, 2024) | ||
7-100093122-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
7-100093128-T-C | not specified | Uncertain significance (May 11, 2022) | ||
7-100093133-C-T | not specified | Likely benign (Jan 04, 2024) | ||
7-100093353-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
7-100093358-T-A | not specified | Uncertain significance (Jul 19, 2023) | ||
7-100093380-C-T | not specified | Uncertain significance (Jun 21, 2023) | ||
7-100093384-C-T | Benign (Aug 18, 2018) | |||
7-100094229-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
7-100094248-C-G | MCM7-related disorder | Likely benign (May 11, 2018) | ||
7-100094322-G-C | not specified | Uncertain significance (Sep 12, 2023) | ||
7-100094334-T-C | not specified | Uncertain significance (Sep 27, 2022) | ||
7-100094340-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
7-100095391-T-G | not specified | Uncertain significance (Jan 26, 2023) | ||
7-100095423-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
7-100095433-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
7-100095450-T-C | Meier-Gorlin syndrome | Pathogenic (-) | ||
7-100095457-T-C | not specified | Uncertain significance (Jan 29, 2024) | ||
7-100095783-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
7-100095789-C-T | not specified | Uncertain significance (Jan 22, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MCM7 | protein_coding | protein_coding | ENST00000303887 | 15 | 9213 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.94e-24 | 0.000721 | 125597 | 0 | 151 | 125748 | 0.000601 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.723 | 498 | 455 | 1.10 | 0.0000301 | 4647 |
Missense in Polyphen | 136 | 167.6 | 0.81144 | 1706 | ||
Synonymous | -3.41 | 222 | 166 | 1.34 | 0.00000973 | 1465 |
Loss of Function | 0.158 | 37 | 38.1 | 0.972 | 0.00000211 | 406 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000866 | 0.000865 |
Ashkenazi Jewish | 0.00218 | 0.00218 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000584 | 0.000580 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000850 | 0.000850 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000269|PubMed:15210935, ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:9305914}.;
- Pathway
- Cell cycle - Homo sapiens (human);DNA replication - Homo sapiens (human);Cell Cycle;miRNA Regulation of DNA Damage Response;Retinoblastoma (RB) in Cancer;G1 to S cell cycle control;DNA Replication;cdk regulation of dna replication;Activation of ATR in response to replication stress;G2/M Checkpoints;Cell Cycle Checkpoints;Activation of the pre-replicative complex;Unwinding of DNA;Mitotic G1-G1/S phases;Orc1 removal from chromatin;DNA Replication;Switching of origins to a post-replicative state;DNA strand elongation;Synthesis of DNA;S Phase;G1/S Transition;Assembly of the pre-replicative complex;DNA Replication Pre-Initiation;M/G1 Transition;Cell Cycle;TNFalpha;Cell Cycle, Mitotic;ATR signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.414
Intolerance Scores
- loftool
- 0.980
- rvis_EVS
- -1.26
- rvis_percentile_EVS
- 5.31
Haploinsufficiency Scores
- pHI
- 0.936
- hipred
- Y
- hipred_score
- 0.779
- ghis
- 0.698
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mcm7
- Phenotype
- cellular phenotype; growth/size/body region phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- mcm7
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;DNA replication;DNA unwinding involved in DNA replication;DNA replication initiation;cellular response to DNA damage stimulus;cell population proliferation;regulation of phosphorylation;response to drug;cellular response to epidermal growth factor stimulus;cellular response to xenobiotic stimulus
- Cellular component
- nuclear chromosome, telomeric region;chromatin;nucleus;nucleoplasm;nucleolus;cytosol;membrane;MCM complex
- Molecular function
- DNA binding;single-stranded DNA binding;ATP-dependent DNA helicase activity;protein binding;ATP binding